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Abstract
Background: Poor ovarian responsemanagement is a complex and controversial issue
in the field of reproductive medicine.
Objective: The aim of this study was to apply double stimulation in the same cycle
in unexpected poor responders in POSEIDON classification group 1, sub group 2a
and compare assisted reproductive technology outcomes between luteal phase and
follicular phase ovarian stimulation.
Materials and Methods: In this cross-sectional study, 10 women with age < 35 yr,
antral follicle count > 5, and anti-müllerian hormone > 1.2 ng/mL were enrolled. All
participants received conventional antagonist protocol in the follicular phase and only
the cycles with retrieved oocytes < 4 in this phase included. The luteal phase ovarian
stimulation was initiated from the day of first oocytes retrieval by 300 IU of human
menopausal gonadotropin / day. When dominant follicles amounted to 14 mm in mean
diameter, 0.25 mg/day of gonadotropin-releasing hormone antagonist was initiated
and 10,000 IU human chorionic gonadotropin was injected when at least two follicles
with a mean diameter of 17 mm were observed. Oocyte retrieval was carried out 34-36
hr following human chorionic gonadotropin injection. Finally, a comparison was made
between the two phase in terms of the number of retrieved oocytes as well as the
number of obtained embryos and fertilization rates.
Results: Numbers of retrieved oocytes (p = 0.004), mature oocytes (p = 0.016), and
embryos (p = 0.013) was significantly higher in luteal phase in compared with follicular
phase. Quality of embryos was similar in two phases.
Conclusion: Double stimulation protocol can increase number of retrieved oocytes in
unexpected PORs.
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1. Introduction
Poor ovarian response in women treated with
in vitro fertilization (IVF) is one of the major
challenges in this field. The incidence of poor
ovarian response in recent studies is estimated to
be 9-24% of women undergoing IVF undergoing
IVF (1). However, the clinical management of poor
ovarian responders (PORs) still remains a matter
of controversy. Researchers have recommended
several strategies to manage PORs, but the fact
remains that there is no general agreement on the
best treatment protocol for each subgroup. There
is no suitable treatment protocol for unexpected
PORs during the ART cycles (2). The concept
of unexpected PORs is usually attributed to the
patients with normal ovarian reserve aged < 35
years and poor ovarian responses to controlled
ovarian hyperstimulation (COH) and few retrieved
oocytes (3).
To reduce the heterogeneity of PORs, the
new POSEIDON classification (Patient-oriented
Strategies Encompassing Individualize D Oocyte
Number) was developed to provide a higher
detailed classification of these patients (4). This
classification has distinguished between those
who unexpectedly respond poorly to exogenous
stimulation and those whose response to
stimulation is invariably poor, that is, between good
and poor ovarian reserve patients, respectively.
It is based on age, ovarian biomarkers (i.e., antral
follicle count (AFC) and anti-müllerian hormone
(AMH)), and previous ovarian response (5). On
the basis of POSEIDON stratification, group 1,
sub-group 2a comprised of young patients aged
< 35 yr with adequate pre-stimulation ovarian
reserve parameters (AFC > 5, AMH > 1.2 ng/mL,
oocyte < 4), and with an unexpected poor or
sub-optimal ovarian response (6). For managing
a poor responder, varying strategies have been
suggested; such as increase the dose of FSH,
recombinant luteinizing hormone supplementation
and dehydroepiandrosterone supplementation
before COH (2). Patients with low ovarian reserve,
both in POSEIDON groups 3 and 4 need special
attention in terms of pretreatment strategy, ovarian
stimulation, adjuvant treatment, aswell as ovulation
trigger strategy. These strategies can optimize
the likelihood of having at least one euploid
blastocyst for transfer (7). The pathophysiological
mechanisms explained the hyporesponse to
gonadotropin stimulation have yet to be known.
However, factors such as specific genotypic traits
and environmental contaminants are supposed to
contribute to the matter. Genetic polymorphisms
affecting the gonadotropins and their receptors, in
particular, may affect ovarian stimulation results.
(8). The combination of conventional follicular and
luteal phase stimulation is achieved by double
stimulation in the same ovarian cycle (9). For
infertile women, luteal phase ovarian stimulation
(LPOS) has been identified as a feasible protocol.
The high levels of progesterone in the luteal phase
prevent the premature luteinizing hormone surge;
this event is definitely beneficial for PORs (10). The
aim of this study was to apply double stimulation in
the same cycle in unexpected PORs in POSEIDON
classification group 1, sub-group 2a and compare
ART outcomes between LPOS and FPOS.
2. Materials and Methods
In this cross-sectional study, we reviewed the
records of women referred to Yazd Reproductive
Sciences Institute, Yazd, Iran for infertility treatment
from April to September 2019. All women aged
< 35 yr with sufficient pre stimulation ovarian
reserve parameters (AFC > 5, AMH > 1.2 ng/mL)
were enrolled in the study. Our exclusion criteria
were severe male factor, severe endometriosis,
hydro salpinx, and the history of any endocrine
disorders except PCOS.The GnRH antagonist
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protocol was used to treat all participants in the
follicular phase by injecting 150 IU recombinant
human follicle stimulating hormone (Cinal-F, Iran),
subcutaneously. After five days, vaginal ultrasound
was serially performed, and when a mature
follicle (≥ 14 mm) was detected, a 0.25 mg/daily
GnRH antagonists (Cetrotide (Cetrorelix); Merck
Serono Laboratories, Aubonne, Switzerland) was
subcutaneously injected. After observingleast
two 17 mm-diameter follicles, 0.2 mg GnRH-a
(Decapeptyl, Ferring Co., Germany) was injected
subcutaneously as well. 36 hr later, transvaginal
oocyte retrieval was performed under sedation.
All embryos were morphologically evaluated on
the second day after the ovarian puncture and
accomplished to IVF or intra-cytoplasmic sperm
injection (ICSI). In the cases with < 4 retrieved
oocytes, the LPOS was initiated with 300 IU of
HMG (Merional, IBSA, Lugano, Switzerland) on first
retrieval day and embryos were vitrified. Serial
vaginal ultrasound was performed to evaluate the
ovarian response. GnRH antagonist (0.25 mg/day)
was started when the dominant follicles reached 14
mm in mean diameter, and continued until the day
of hCG injection. When at least two follicles with a
mean diameter of 17 mm were observed, 10,000
IU hCGs (Pregnyl, Organon, the Netherlands) were
injected and 34 to 36 hours after that, oocyte
retrieval was carried out. Conventional IVF or ICSI
were performed similar to conventional antagonist
protocol, and all embryos were cryopreserved
by vitrification method. Finally, a comparison was
made between the two phases in terms of the
number of retrieved oocytes as well as the number
of obtained embryos and fertilization rates.
2.1. Ethical consideration
This study was approved by the ethics
committee of the Yazd Reproductive Sciences
Institute, Shahid Sadoughi University of Medical
Sciences, Yazd, Iran (IR.SSU.RSI.REC.1397.031).
2.2. Statistical analysis
SPSS software version 15.0 for windows
(Statistical Package for the Social Sciences,
Chicago, IL, USA) was used for data analysis using
the Student’s t test and Chi-square test. P-value <
0.05 was considered as statistically significant.
3. Results
A total of 10 women who met our inclusion
criteria were enrolled in the study (Table I). The
number of retrieved oocytes, mature oocytes, and
embryos was significantly higher in luteal phase in
comparison with the follicular phase (p = 0.004, p
= 0.016, and p = 0.013, respectively). The quality of
embryos were similar between embryos obtained
after follicular or luteal phase stimulation (p = 1.000)
(Table II).
Table I. Basic characteristics of the participants
Variables Outcome
Age (yr) * 30.70 ± 3.40
Duration of infertility (yr) * 5.95 ± 3.13
AMH (IU/L) * 5.45 ± 2.80
BMI* 24.23 ± 1.31
Etiology of infertility**
PCOS 3 (30)
Mal factor 2 (20)
Unexplained 1 (10)
Mixed 4 (40)
* Data presented as Mean ± SD. ** Data presented as n (%), AMH: Anti-mullerian hormone; BMI: Body mass index
https://doi.org/10.18502/ijrm.v13i6.7287 Page 467
International Journal of Reproductive BioMedicine Eftekhar et al.
Table II. Comparison of ART outcomes between the two study groups
Variables Follicular cycle Luteal cycle P-value
Retrieved oocytes (1)* 1.9 ± 1.10 9.22 ± 6.81 0.004
Mature oocytes (1)* 1.70 ± 0.82 7.87 ± 5.02 0.016
Embryo (1)* 1.33 ± 0.51 4.85 ± 2.85 0.013
Quality of embryos**
A 33.3 28.6 1.000
B 66.7 71.4
Maturation rate** 94.17 78.12 0.038
Cleavage rate ** 88 100 0.30
Fertilization rate ** 90.48 53.75 0.009
Cycle duration (day)* 10.70 ± 3.16 8.50 ± 3.53 0.16
Gonadotropin dose (8)* 639.83 ± 202.33 1131 ± 357.77 0.070
Estradiol level in trigger day (pg/ml)* 572.50 ± 533 1884.90 ± 1668 0.029
*Data presented as Mean ± SD and analyzed by Student’s t test, ** Data presented as %.and analyzed by Chi-square test
4. Discussion
In this pilot study, we made attempts to
show if dual stimulation can be considered
a good option for the management of PORs
classified as group 1, sub-group2a? Our
results indicated a higher significant number
of retrieved oocytes and embryos in luteal
phase compared with follicular phase in these
subgroups.
In a study by Kuang and co-workers, a mild
ovarian stimulation was conducted on 38 women.
They administered the human menopausal
gonadotropin and letrozole to women after the
first oocyte retrieval. When dominant follicles
had matured, the second oocyte retrieval was
performed. Their results showed that double
ovarian stimulations in the same menstrual cycle
provided more opportunities in poor responders
(according to Bologna criteria) for oocyte retrieval.
They concluded that the luteal phase stimulation
can lead to more retrieved oocytes in the short
time. (9).
According to our review of literature, this
study is the first to compare follicular and luteal
ovarian stimulation in an ovarian stimulation cycle
in unexpected PORs. This study was different
from others in starting ovarian stimulation in
the day of first oocyte retrieval. The findings
demonstrated that earlier onset of ovarian
stimulation in the luteal phase fails to have a
negative effect on ovulation stimulation results;
it shortens the duration of stimulation as well
as the patient’s stay. For the inappropriate
condition of the endometrium, all embryos
were cryopreserved. Similarly, in a retrospective
study conducted by Zhang, a comparison of
the clinical outcomes of follicular and luteal
phase and double ovarian stimulation in the
patients with PORs (Bologna criteria) undergoing
IVF was made, the results of which indicated
longer stimulation, higher dosages of HMG,
and higher MII oocyte rates in Luteal phase
(p < 0.001). They did not report the significant
difference in clinical pregnancy (CPR) and live
birth rate (LBR) between the two groups. The
number of oocytes retrieved in the luteal phase
stimulation protocol was higher in the double
ovarian stimulation group, however, the luteal
phase stimulation showed a lower rate of MII
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oocytes (p = 0.031). In addition, there were no
statistical differences between CPR and LBR
(11).
Concerns have grown over the increased
aneuploidy in embryos obtained during the
luteal phase. In a study, Ubaldi and co-workers
compared the euploid blastocyst formation rates
in the follicular versus luteal phase in the same
menstrual cycle between the patients with reduced
ovarian reserve. Their results showed no significant
difference in the number of retrieved oocytes, MII
oocytes, biopsied blastocysts per stimulated cycle,
and also the euploid blastocyst rate calculated
either per biopsied blastocyst or injected MII
oocyte in the follicular vs luteal phase stimulation
(12). Another study by de Almeida Cardoso and
colleagues concluded that the double stimulation
protocol significantly increased the number of
retrieved oocytes and mature oocytes to be
injected, but there were no significant differences
in the fertilization and blastocyst rates (13).
5. Conclusion
For generating an adequate number of oocytes,
it stands to reason to accept that double stimulation
is advantageous for patients with unexpected
PORs. Accumulation of oocytes in a single cycle of
stimulation that helps minimize the time in which
it will be performed is the greatest benefit of this
protocol. Moreover, it bears the potential to allow
generating a larger number of embryos, which can
then be genetically evaluated, thereby favoring the
final clinical result.
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